Advertisement
Screener

DEXCOM, INC. (DXCM) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

DEXCOM INC Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • DEXCOM INC return tang equity for the quarter ending 2024-12-31 was 29.15%, a 2.77% increase year-over-year.
  • DEXCOM INC return tang equity for the quarter ending 2024-06-30 was 29.29%, a 55.80% increase year-over-year.
  • DEXCOM INC return tang equity for the quarter ending 2024-03-31 was 30.60%, a 112.80% increase year-over-year.
  • DEXCOM INC return tang equity for the quarter ending 2023-12-31 was 28.37%, a 60.69% increase year-over-year.
  • DEXCOM INC return tang equity for fiscal 2024 was 29.15%, a 2.77% increase from fiscal 2023.
  • DEXCOM INC return tang equity for fiscal 2023 was 28.37%, a 60.69% increase from fiscal 2022.
  • DEXCOM INC return tang equity for fiscal 2022 was 17.65%.
  • DEXCOM INC return tang equity for fiscal 2020 was 30.45%, a 159.62% increase from fiscal 2019.
Available history
2009-12-31 to 2024-12-31
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2024-12-3129.15%$576.2M$1.98B
2024-06-3029.29%$666.9M$2.28B
2024-03-3130.60%$639.3M$2.09B
2023-12-3128.37%$541.5M$1.91B
2023-09-3018.22%$377M$2.07B
2023-06-3018.80%$357.5M$1.9B
2023-03-3114.38%$292.5M$2.03B
2022-12-3117.65%$341.2M$1.93B
2022-09-3013.80%$244.1M$1.77B
2022-06-3010.47%$230.2M$2.2B
2022-03-3112.09%$257.7M$2.13B
2021-12-3110.93%$216.9M$1.98B
2021-09-3030.02%$633.5M$2.11B
2021-06-3031.29%$618.4M$1.98B
2021-03-3131.15%$586.3M$1.88B
2020-12-3130.45%$549.7M$1.81B
2020-09-3015.63%$231.1M$1.48B
2020-06-3015.36%$204.7M$1.33B
2020-03-3116.19%$147.9M$913.8M
2019-12-3111.73%$101.1M$861.9M
2019-09-30-23.03%-$171.3M$743.8M
2019-06-30-25.54%-$170.5M$667.5M
2019-03-31-20.03%-$129.8M$647.9M
2018-12-31-19.78%-$127.1M$642.5M
2018-09-307.97%$43.2M$541.7M
2018-06-30-1.15%-$5.4M$468.1M
2018-03-31-8.03%-$32.7M$407.3M
2017-12-31-12.39%-$50.2M$405.2M
2017-09-30-13.03%-$48.2M$369.9M
2017-06-30-19.13%-$65M$339.7M
2017-03-31-33.33%-$88.1M$264.3M
2016-12-31-24.26%-$65.6M$270.4M
2016-09-30-22.87%-$56.7M$247.9M
2016-06-30-34.58%-$80.4M$232.5M
2016-03-31-28.35%-$63.9M$225.4M
2015-12-31-26.74%-$57.6M$215.4M
2015-09-30-30.91%-$57.8M$187M
2015-06-30-12.47%-$20.5M$164.4M
2015-03-31-15.97%-$22.8M$142.8M
2014-12-31-16.67%-$22.4M$134.4M
2014-09-30-24.28%-$26.3M$108.3M
2014-06-30-29.17%-$27.1M$92.9M
2014-03-31-37.45%-$31.2M$83.3M
2013-12-31-38.50%-$29.8M$77.4M
2013-09-30-52.81%-$35.7M$67.6M
2013-06-30-72.09%-$47M$65.2M
2013-03-31-77.59%-$51.6M$66.5M
2012-12-31-78.11%-$54.6M$69.9M
2012-09-30-75.63%-$58.31M$77.09M
2012-06-30-61.58%-$54.28M$88.15M
2012-03-31-48.71%-$46.95M$96.39M
2011-12-31-42.78%-$44.7M$104.5M
2011-09-30-37.44%-$42.34M$113.07M
2011-06-30-34.92%-$42.46M$121.58M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2024-12-3129.15%$576.2M$1.98B
2023-12-3128.37%$541.5M$1.91B
2022-12-3117.65%$341.2M$1.93B
2020-12-3130.45%$549.7M$1.81B
2019-12-3111.73%$101.1M$861.9M
2018-12-31-19.78%-$127.1M$642.5M
2017-12-31-12.39%-$50.2M$405.2M
2016-12-31-24.26%-$65.6M$270.4M
2015-12-31-26.74%-$57.6M$215.4M
2014-12-31-16.67%-$22.4M$134.4M
2013-12-31-38.50%-$29.8M$77.4M
2012-12-31-77.97%-$54.5M$69.9M
2011-12-31-42.78%-$44.7M$104.5M
2010-12-31-90.49%-$55.2M$61M
2009-12-31290.89%-$53.52M-$18.4M

Similar stocks

Stock NameCountryMarket CapPE Ratio
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44